Contribution of Hypoxia Inducible Factor-1 During Viral Infections

Overview

Journal Virulence

Specialty Microbiology

Date 2020 Nov 2

PMID 33135539

Citations 21

Authors

Antonia Reyes

Nicolas Corrales

Nicolas M S Galvez

Susan M Bueno

Alexis M Kalergis

Pablo A Gonzalez

Affiliations

Soon will be listed here.

Abstract

Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that plays critical roles during the cellular response to hypoxia. Under normoxic conditions, its function is tightly regulated by the degradation of its alpha subunit (HIF-1α), which impairs the formation of an active heterodimer in the nucleus that otherwise regulates the expression of numerous genes. Importantly, HIF-1 participates in both cancer and infectious diseases unveiling new therapeutic targets for those ailments. Here, we discuss aspects related to the activation of HIF-1, the effects of this transcription factor over immune system components, as well as the involvement of HIF-1 activity in response to viral infections in humans. Although HIF-1 is currently being assessed in numerous clinical settings as a potential therapy for different diseases, up to date, there are no clinical studies evaluating the pharmacological modulation of this transcription factor as a possible new antiviral treatment. However, based on the available evidence, clinical trials targeting this molecule are likely to occur soon. In this review we discuss the role of HIF-1 in viral immunity, the modulation of HIF-1 by different types of viruses, as well as the effects of HIF-1 over their life cycle and the potential use of HIF-1 as a new target for the treatment of viral infections.

Citing Articles

Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations.

Abdelmageed A, Dewhurst S, Ferran M Viruses. 2025; 17(1).

PMID: 39861805 PMC: 11768927. DOI: 10.3390/v17010016.

Identification of stimuli that enhance human herpesvirus 6A (HHV-6A) replication and reconstitution.

Reich J, Serdar D, Weissmann A, Kaufer B J Virol. 2024; 98(12):e0148524.

PMID: 39508597 PMC: 11651002. DOI: 10.1128/jvi.01485-24.

Biomolecular Dynamics of Nitric Oxide Metabolites and HIF1α in HPV Infection.

Matei C, Nicolae I, Mitran M, Mitran C, Ene C, Nicolae G Biomolecules. 2024; 14(9).

PMID: 39334938 PMC: 11429777. DOI: 10.3390/biom14091172.

Oncolytic vesicular stomatitis virus alone or in combination with JAK inhibitors is effective against ovarian cancer.

Geoffroy K, Mullins-Dansereau V, Leclerc-Desaulniers K, Viens M, Bourgeois-Daigneault M Mol Ther Oncol. 2024; 32(3):200826.

PMID: 39006945 PMC: 11246050. DOI: 10.1016/j.omton.2024.200826.

Identification of the Hub Genes Involved in Chikungunya Viral Infection.

Ahmed S, Salem A, Hamadan N, Khalfallah M, Alfaki M Cureus. 2024; 16(4):e57603.

PMID: 38707036 PMC: 11069395. DOI: 10.7759/cureus.57603.

References

Huang H, Fan Y, Gao Z, Wang W, Shao N, Zhang L . HIF-1α contributes to Ang II-induced inflammatory cytokine production in podocytes. BMC Pharmacol Toxicol. 2019; 20(1):59. PMC: 6796393. DOI: 10.1186/s40360-019-0340-8. View

Semenza G . Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003; 3(10):721-32. DOI: 10.1038/nrc1187. View

Zhang M, Wu Y, Wang M, Wang Y, Tausif R, Yang Y . Genistein rescues hypoxia-induced pulmonary arterial hypertension through estrogen receptor and β-adrenoceptor signaling. J Nutr Biochem. 2018; 58:110-118. DOI: 10.1016/j.jnutbio.2018.04.016. View

Ravi R, Mookerjee B, Bhujwalla Z, Sutter C, Artemov D, Zeng Q . Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha. Genes Dev. 2000; 14(1):34-44. PMC: 316350. View

Rapa S, Di Iorio B, Campiglia P, Heidland A, Marzocco S . Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites. Int J Mol Sci. 2020; 21(1). PMC: 6981831. DOI: 10.3390/ijms21010263. View

Kothari S, Cizeau J, McMillan-Ward E, Israels S, Bailes M, Ens K . BNIP3 plays a role in hypoxic cell death in human epithelial cells that is inhibited by growth factors EGF and IGF. Oncogene. 2003; 22(30):4734-44. DOI: 10.1038/sj.onc.1206666. View

Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu M . Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res. 2000; 60(6):1541-5. View

Singh R, Lang F, Pei Y, Jha H, Robertson E . Metabolic reprogramming of Kaposi's sarcoma associated herpes virus infected B-cells in hypoxia. PLoS Pathog. 2018; 14(5):e1007062. PMC: 5963815. DOI: 10.1371/journal.ppat.1007062. View

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

10.

Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

11.

Palazon A, Goldrath A, Nizet V, Johnson R . HIF transcription factors, inflammation, and immunity. Immunity. 2014; 41(4):518-28. PMC: 4346319. DOI: 10.1016/j.immuni.2014.09.008. View

12.

Jiang B, Agani F, Passaniti A, Semenza G . V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res. 1997; 57(23):5328-35. View

13.

Forsythe J, Jiang B, Iyer N, Agani F, Leung S, Koos R . Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 1996; 16(9):4604-13. PMC: 231459. DOI: 10.1128/MCB.16.9.4604. View

14.

Dang E, Barbi J, Yang H, Jinasena D, Yu H, Zheng Y . Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell. 2011; 146(5):772-84. PMC: 3387678. DOI: 10.1016/j.cell.2011.07.033. View

15.

Arias-Reyes C, Zubieta-DeUrioste N, Poma-Machicao L, Aliaga-Raduan F, Carvajal-Rodriguez F, Dutschmann M . Does the pathogenesis of SARS-CoV-2 virus decrease at high-altitude?. Respir Physiol Neurobiol. 2020; 277:103443. PMC: 7175867. DOI: 10.1016/j.resp.2020.103443. View

16.

Sitkovsky M, Lukashev D . Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol. 2005; 5(9):712-21. DOI: 10.1038/nri1685. View

17.

Tolonen J, Heikkila M, Malinen M, Lee H, Palvimo J, Wei G . A long hypoxia-inducible factor 3 isoform 2 is a transcription activator that regulates erythropoietin. Cell Mol Life Sci. 2019; 77(18):3627-3642. PMC: 7452874. DOI: 10.1007/s00018-019-03387-9. View

18.

Pugh C, Ratcliffe P . Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med. 2003; 9(6):677-84. DOI: 10.1038/nm0603-677. View

19.

Netea M, Schlitzer A, Placek K, Joosten L, Schultze J . Innate and Adaptive Immune Memory: an Evolutionary Continuum in the Host's Response to Pathogens. Cell Host Microbe. 2019; 25(1):13-26. DOI: 10.1016/j.chom.2018.12.006. View

20.

Volm M, Koomagi R . Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Res. 2000; 20(3A):1527-33. View